nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0842	0.0951	CbGbCtD
Simvastatin—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0756	0.0853	CbGbCtD
Simvastatin—ABCC2—Sulfasalazine—ankylosing spondylitis	0.074	0.0836	CbGbCtD
Simvastatin—SLCO1A2—Prednisone—ankylosing spondylitis	0.0714	0.0806	CbGbCtD
Simvastatin—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0446	0.0503	CbGbCtD
Simvastatin—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0371	0.0419	CbGbCtD
Simvastatin—ABCC2—Dexamethasone—ankylosing spondylitis	0.0369	0.0417	CbGbCtD
Simvastatin—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0358	0.0404	CbGbCtD
Simvastatin—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0338	0.0381	CbGbCtD
Simvastatin—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0318	0.0359	CbGbCtD
Simvastatin—ABCC2—Methotrexate—ankylosing spondylitis	0.0297	0.0335	CbGbCtD
Simvastatin—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0247	0.0278	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0247	0.0278	CbGbCtD
Simvastatin—CYP2C19—Prednisone—ankylosing spondylitis	0.0239	0.027	CbGbCtD
Simvastatin—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0235	0.0265	CbGbCtD
Simvastatin—ABCB1—Betamethasone—ankylosing spondylitis	0.0207	0.0234	CbGbCtD
Simvastatin—ABCB1—Prednisolone—ankylosing spondylitis	0.0204	0.0231	CbGbCtD
Simvastatin—ABCB1—Prednisone—ankylosing spondylitis	0.0193	0.0218	CbGbCtD
Simvastatin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0191	0.0215	CbGbCtD
Simvastatin—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0185	0.0209	CbGbCtD
Simvastatin—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0178	0.0201	CbGbCtD
Simvastatin—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0149	0.0168	CbGbCtD
Simvastatin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0145	0.0163	CbGbCtD
Simvastatin—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0124	0.014	CbGbCtD
Simvastatin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0124	0.014	CbGbCtD
Simvastatin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0122	0.0138	CbGbCtD
Simvastatin—ABCB1—Dexamethasone—ankylosing spondylitis	0.012	0.0136	CbGbCtD
Simvastatin—CYP3A4—Prednisone—ankylosing spondylitis	0.0116	0.013	CbGbCtD
Simvastatin—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0113	0.0128	CbGbCtD
Simvastatin—ABCB1—Methotrexate—ankylosing spondylitis	0.00968	0.0109	CbGbCtD
Simvastatin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00721	0.00814	CbGbCtD
Simvastatin—ITGB2—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—KIR3DL1—ankylosing spondylitis	0.00112	0.195	CbGpPWpGaD
Simvastatin—ITGB2—Beta2 integrin cell surface interactions—CD40LG—ankylosing spondylitis	0.000465	0.0809	CbGpPWpGaD
Simvastatin—ITGB2—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-C—ankylosing spondylitis	0.00037	0.0643	CbGpPWpGaD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—ankylosing spondylitis	0.000368	0.064	CbGpPWpGaD
Simvastatin—Vision blurred—Prednisolone—ankylosing spondylitis	0.000317	0.00292	CcSEcCtD
Simvastatin—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000312	0.00288	CcSEcCtD
Simvastatin—Depression—Prednisone—ankylosing spondylitis	0.000312	0.00288	CcSEcCtD
Simvastatin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000311	0.00287	CcSEcCtD
Simvastatin—Erythema—Triamcinolone—ankylosing spondylitis	0.00031	0.00285	CcSEcCtD
Simvastatin—Erythema—Methylprednisolone—ankylosing spondylitis	0.000309	0.00285	CcSEcCtD
Simvastatin—Angioedema—Prednisolone—ankylosing spondylitis	0.000308	0.00284	CcSEcCtD
Simvastatin—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000307	0.00283	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000306	0.00282	CcSEcCtD
Simvastatin—Malaise—Prednisolone—ankylosing spondylitis	0.000304	0.0028	CcSEcCtD
Simvastatin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000303	0.00279	CcSEcCtD
Simvastatin—Vertigo—Prednisolone—ankylosing spondylitis	0.000302	0.00279	CcSEcCtD
Simvastatin—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00029	0.00268	CcSEcCtD
Simvastatin—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000288	0.00265	CcSEcCtD
Simvastatin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000287	0.00265	CcSEcCtD
Simvastatin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000287	0.00264	CcSEcCtD
Simvastatin—Alopecia—Dexamethasone—ankylosing spondylitis	0.000285	0.00263	CcSEcCtD
Simvastatin—Alopecia—Betamethasone—ankylosing spondylitis	0.000285	0.00263	CcSEcCtD
Simvastatin—Discomfort—Prednisolone—ankylosing spondylitis	0.000283	0.00261	CcSEcCtD
Simvastatin—Angioedema—Triamcinolone—ankylosing spondylitis	0.000283	0.00261	CcSEcCtD
Simvastatin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000282	0.0026	CcSEcCtD
Simvastatin—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000281	0.00259	CcSEcCtD
Simvastatin—Erythema—Dexamethasone—ankylosing spondylitis	0.000281	0.00259	CcSEcCtD
Simvastatin—Erythema—Betamethasone—ankylosing spondylitis	0.000281	0.00259	CcSEcCtD
Simvastatin—Malaise—Triamcinolone—ankylosing spondylitis	0.000279	0.00257	CcSEcCtD
Simvastatin—Malaise—Methylprednisolone—ankylosing spondylitis	0.000279	0.00257	CcSEcCtD
Simvastatin—Vertigo—Triamcinolone—ankylosing spondylitis	0.000278	0.00256	CcSEcCtD
Simvastatin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000277	0.00256	CcSEcCtD
Simvastatin—Oedema—Prednisolone—ankylosing spondylitis	0.000275	0.00253	CcSEcCtD
Simvastatin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000275	0.00253	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000273	0.00251	CcSEcCtD
Simvastatin—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00027	0.00249	CcSEcCtD
Simvastatin—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000268	0.00247	CcSEcCtD
Simvastatin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000264	0.00243	CcSEcCtD
Simvastatin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000263	0.00242	CcSEcCtD
Simvastatin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000263	0.00242	CcSEcCtD
Simvastatin—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000262	0.00242	CcSEcCtD
Simvastatin—Depression—Methotrexate—ankylosing spondylitis	0.000261	0.0024	CcSEcCtD
Simvastatin—Flushing—Prednisone—ankylosing spondylitis	0.000261	0.0024	CcSEcCtD
Simvastatin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000261	0.0024	CcSEcCtD
Simvastatin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000261	0.0024	CcSEcCtD
Simvastatin—Discomfort—Triamcinolone—ankylosing spondylitis	0.00026	0.0024	CcSEcCtD
Simvastatin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00026	0.00239	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000259	0.00239	CcSEcCtD
Simvastatin—Angioedema—Dexamethasone—ankylosing spondylitis	0.000257	0.00237	CcSEcCtD
Simvastatin—Angioedema—Betamethasone—ankylosing spondylitis	0.000257	0.00237	CcSEcCtD
Simvastatin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000254	0.00234	CcSEcCtD
Simvastatin—Malaise—Dexamethasone—ankylosing spondylitis	0.000253	0.00233	CcSEcCtD
Simvastatin—Malaise—Betamethasone—ankylosing spondylitis	0.000253	0.00233	CcSEcCtD
Simvastatin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000253	0.00233	CcSEcCtD
Simvastatin—Oedema—Triamcinolone—ankylosing spondylitis	0.000253	0.00233	CcSEcCtD
Simvastatin—Vertigo—Dexamethasone—ankylosing spondylitis	0.000252	0.00233	CcSEcCtD
Simvastatin—Vertigo—Betamethasone—ankylosing spondylitis	0.000252	0.00233	CcSEcCtD
Simvastatin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000252	0.00232	CcSEcCtD
Simvastatin—Infection—Triamcinolone—ankylosing spondylitis	0.000251	0.00231	CcSEcCtD
Simvastatin—Infection—Methylprednisolone—ankylosing spondylitis	0.00025	0.00231	CcSEcCtD
Simvastatin—Insomnia—Prednisolone—ankylosing spondylitis	0.000248	0.00229	CcSEcCtD
Simvastatin—Alopecia—Prednisone—ankylosing spondylitis	0.000248	0.00229	CcSEcCtD
Simvastatin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000247	0.00227	CcSEcCtD
Simvastatin—Mental disorder—Prednisone—ankylosing spondylitis	0.000246	0.00227	CcSEcCtD
Simvastatin—Erythema—Prednisone—ankylosing spondylitis	0.000245	0.00225	CcSEcCtD
Simvastatin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000239	0.0022	CcSEcCtD
Simvastatin—Myalgia—Betamethasone—ankylosing spondylitis	0.000239	0.0022	CcSEcCtD
Simvastatin—Anxiety—Betamethasone—ankylosing spondylitis	0.000238	0.0022	CcSEcCtD
Simvastatin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000238	0.0022	CcSEcCtD
Simvastatin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000236	0.00218	CcSEcCtD
Simvastatin—Discomfort—Betamethasone—ankylosing spondylitis	0.000236	0.00218	CcSEcCtD
Simvastatin—Pain—Prednisolone—ankylosing spondylitis	0.000235	0.00217	CcSEcCtD
Simvastatin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000235	0.00216	CcSEcCtD
Simvastatin—Vision blurred—Prednisone—ankylosing spondylitis	0.000231	0.00212	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00023	0.00212	CcSEcCtD
Simvastatin—ITGB2—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD40LG—ankylosing spondylitis	0.00023	0.04	CbGpPWpGaD
Simvastatin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00023	0.00212	CcSEcCtD
Simvastatin—Oedema—Betamethasone—ankylosing spondylitis	0.000229	0.00211	CcSEcCtD
Simvastatin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000229	0.00211	CcSEcCtD
Simvastatin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000229	0.00211	CcSEcCtD
Simvastatin—Oedema—Dexamethasone—ankylosing spondylitis	0.000229	0.00211	CcSEcCtD
Simvastatin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000228	0.00211	CcSEcCtD
Simvastatin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000228	0.0021	CcSEcCtD
Simvastatin—Infection—Dexamethasone—ankylosing spondylitis	0.000228	0.0021	CcSEcCtD
Simvastatin—Infection—Betamethasone—ankylosing spondylitis	0.000228	0.0021	CcSEcCtD
Simvastatin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000227	0.00209	CcSEcCtD
Simvastatin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000227	0.00209	CcSEcCtD
Simvastatin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000226	0.00209	CcSEcCtD
Simvastatin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000226	0.00209	CcSEcCtD
Simvastatin—Anaemia—Prednisone—ankylosing spondylitis	0.000226	0.00208	CcSEcCtD
Simvastatin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000225	0.00208	CcSEcCtD
Simvastatin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000224	0.00207	CcSEcCtD
Simvastatin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000224	0.00207	CcSEcCtD
Simvastatin—Angioedema—Prednisone—ankylosing spondylitis	0.000223	0.00206	CcSEcCtD
Simvastatin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000222	0.00205	CcSEcCtD
Simvastatin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000222	0.00205	CcSEcCtD
Simvastatin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000222	0.00205	CcSEcCtD
Simvastatin—Malaise—Prednisone—ankylosing spondylitis	0.000221	0.00203	CcSEcCtD
Simvastatin—Vertigo—Prednisone—ankylosing spondylitis	0.00022	0.00203	CcSEcCtD
Simvastatin—ITGB2—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-B—ankylosing spondylitis	0.000219	0.038	CbGpPWpGaD
Simvastatin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000218	0.00201	CcSEcCtD
Simvastatin—Anorexia—Betamethasone—ankylosing spondylitis	0.000218	0.00201	CcSEcCtD
Simvastatin—Urticaria—Prednisolone—ankylosing spondylitis	0.000218	0.00201	CcSEcCtD
Simvastatin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000218	0.00201	CcSEcCtD
Simvastatin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000217	0.002	CcSEcCtD
Simvastatin—Pain—Triamcinolone—ankylosing spondylitis	0.000216	0.00199	CcSEcCtD
Simvastatin—Chills—Methotrexate—ankylosing spondylitis	0.000211	0.00194	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000209	0.00193	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000209	0.00193	CcSEcCtD
Simvastatin—Arthralgia—Prednisone—ankylosing spondylitis	0.000208	0.00192	CcSEcCtD
Simvastatin—Myalgia—Prednisone—ankylosing spondylitis	0.000208	0.00192	CcSEcCtD
Simvastatin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000208	0.00192	CcSEcCtD
Simvastatin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000208	0.00191	CcSEcCtD
Simvastatin—Anxiety—Prednisone—ankylosing spondylitis	0.000208	0.00191	CcSEcCtD
Simvastatin—Alopecia—Methotrexate—ankylosing spondylitis	0.000208	0.00191	CcSEcCtD
Simvastatin—Insomnia—Betamethasone—ankylosing spondylitis	0.000207	0.00191	CcSEcCtD
Simvastatin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000207	0.00191	CcSEcCtD
Simvastatin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000206	0.0019	CcSEcCtD
Simvastatin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000206	0.0019	CcSEcCtD
Simvastatin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000206	0.0019	CcSEcCtD
Simvastatin—Discomfort—Prednisone—ankylosing spondylitis	0.000206	0.0019	CcSEcCtD
Simvastatin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000206	0.0019	CcSEcCtD
Simvastatin—Erythema—Methotrexate—ankylosing spondylitis	0.000204	0.00188	CcSEcCtD
Simvastatin—ITGB2—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-A—ankylosing spondylitis	0.000203	0.0352	CbGpPWpGaD
Simvastatin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000202	0.00187	CcSEcCtD
Simvastatin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000202	0.00186	CcSEcCtD
Simvastatin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000202	0.00186	CcSEcCtD
Simvastatin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000201	0.00185	CcSEcCtD
Simvastatin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0002	0.00185	CcSEcCtD
Simvastatin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.0002	0.00185	CcSEcCtD
Simvastatin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0002	0.00184	CcSEcCtD
Simvastatin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0002	0.00184	CcSEcCtD
Simvastatin—Oedema—Prednisone—ankylosing spondylitis	0.0002	0.00184	CcSEcCtD
Simvastatin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000199	0.00184	CcSEcCtD
Simvastatin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000199	0.00184	CcSEcCtD
Simvastatin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000199	0.00184	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000199	0.0346	CbGpPWpGaD
Simvastatin—Infection—Prednisone—ankylosing spondylitis	0.000198	0.00183	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000198	0.00182	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000198	0.00182	CcSEcCtD
Simvastatin—Fatigue—Betamethasone—ankylosing spondylitis	0.000198	0.00182	CcSEcCtD
Simvastatin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000198	0.00182	CcSEcCtD
Simvastatin—Pain—Betamethasone—ankylosing spondylitis	0.000196	0.00181	CcSEcCtD
Simvastatin—Pain—Dexamethasone—ankylosing spondylitis	0.000196	0.00181	CcSEcCtD
Simvastatin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000193	0.00178	CcSEcCtD
Simvastatin—Anorexia—Prednisone—ankylosing spondylitis	0.00019	0.00175	CcSEcCtD
Simvastatin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00019	0.00175	CcSEcCtD
Simvastatin—Anaemia—Methotrexate—ankylosing spondylitis	0.000189	0.00174	CcSEcCtD
Simvastatin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000189	0.00174	CcSEcCtD
Simvastatin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000189	0.00174	CcSEcCtD
Simvastatin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000187	0.00173	CcSEcCtD
Simvastatin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000187	0.00173	CcSEcCtD
Simvastatin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000186	0.00172	CcSEcCtD
Simvastatin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000186	0.00171	CcSEcCtD
Simvastatin—Malaise—Methotrexate—ankylosing spondylitis	0.000184	0.0017	CcSEcCtD
Simvastatin—Vertigo—Methotrexate—ankylosing spondylitis	0.000184	0.00169	CcSEcCtD
Simvastatin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000183	0.00169	CcSEcCtD
Simvastatin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000182	0.00168	CcSEcCtD
Simvastatin—Urticaria—Betamethasone—ankylosing spondylitis	0.000182	0.00168	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000182	0.00168	CcSEcCtD
Simvastatin—Dizziness—Prednisolone—ankylosing spondylitis	0.000182	0.00167	CcSEcCtD
Simvastatin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000181	0.00167	CcSEcCtD
Simvastatin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000181	0.00167	CcSEcCtD
Simvastatin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000181	0.00167	CcSEcCtD
Simvastatin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000181	0.00167	CcSEcCtD
Simvastatin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000181	0.00167	CcSEcCtD
Simvastatin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000181	0.00167	CcSEcCtD
Simvastatin—Insomnia—Prednisone—ankylosing spondylitis	0.000181	0.00166	CcSEcCtD
Simvastatin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000179	0.00165	CcSEcCtD
Simvastatin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000179	0.00165	CcSEcCtD
Simvastatin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000178	0.00164	CcSEcCtD
Simvastatin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000176	0.00162	CcSEcCtD
Simvastatin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000174	0.0016	CcSEcCtD
Simvastatin—Chest pain—Methotrexate—ankylosing spondylitis	0.000174	0.0016	CcSEcCtD
Simvastatin—Myalgia—Methotrexate—ankylosing spondylitis	0.000174	0.0016	CcSEcCtD
Simvastatin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000174	0.0016	CcSEcCtD
Simvastatin—Rash—Prednisolone—ankylosing spondylitis	0.000173	0.0016	CcSEcCtD
Simvastatin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000173	0.0016	CcSEcCtD
Simvastatin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000172	0.00159	CcSEcCtD
Simvastatin—Fatigue—Prednisone—ankylosing spondylitis	0.000172	0.00159	CcSEcCtD
Simvastatin—Headache—Prednisolone—ankylosing spondylitis	0.000172	0.00159	CcSEcCtD
Simvastatin—Discomfort—Methotrexate—ankylosing spondylitis	0.000172	0.00159	CcSEcCtD
Simvastatin—Constipation—Prednisone—ankylosing spondylitis	0.000171	0.00157	CcSEcCtD
Simvastatin—Confusional state—Methotrexate—ankylosing spondylitis	0.000168	0.00155	CcSEcCtD
Simvastatin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000167	0.00154	CcSEcCtD
Simvastatin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000167	0.00154	CcSEcCtD
Simvastatin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000167	0.00154	CcSEcCtD
Simvastatin—Infection—Methotrexate—ankylosing spondylitis	0.000166	0.00153	CcSEcCtD
Simvastatin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000165	0.00152	CcSEcCtD
Simvastatin—Asthenia—Betamethasone—ankylosing spondylitis	0.000164	0.00152	CcSEcCtD
Simvastatin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000164	0.00152	CcSEcCtD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000164	0.0285	CbGpPWpGaD
Simvastatin—ITGB2—amb2 Integrin signaling—TNF—ankylosing spondylitis	0.000164	0.0285	CbGpPWpGaD
Simvastatin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000163	0.00151	CcSEcCtD
Simvastatin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000163	0.0015	CcSEcCtD
Simvastatin—Nausea—Prednisolone—ankylosing spondylitis	0.000163	0.0015	CcSEcCtD
Simvastatin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000162	0.00149	CcSEcCtD
Simvastatin—Pruritus—Betamethasone—ankylosing spondylitis	0.000162	0.00149	CcSEcCtD
Simvastatin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000161	0.00148	CcSEcCtD
Simvastatin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00016	0.00148	CcSEcCtD
Simvastatin—Rash—Triamcinolone—ankylosing spondylitis	0.000159	0.00147	CcSEcCtD
Simvastatin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000159	0.00147	CcSEcCtD
Simvastatin—Anorexia—Methotrexate—ankylosing spondylitis	0.000159	0.00147	CcSEcCtD
Simvastatin—Rash—Methylprednisolone—ankylosing spondylitis	0.000159	0.00147	CcSEcCtD
Simvastatin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000159	0.00146	CcSEcCtD
Simvastatin—Urticaria—Prednisone—ankylosing spondylitis	0.000159	0.00146	CcSEcCtD
Simvastatin—Headache—Triamcinolone—ankylosing spondylitis	0.000158	0.00146	CcSEcCtD
Simvastatin—Headache—Methylprednisolone—ankylosing spondylitis	0.000158	0.00146	CcSEcCtD
Simvastatin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000158	0.00145	CcSEcCtD
Simvastatin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000158	0.00145	CcSEcCtD
Simvastatin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000157	0.00145	CcSEcCtD
Simvastatin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000157	0.00145	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000152	0.0014	CcSEcCtD
Simvastatin—Dizziness—Betamethasone—ankylosing spondylitis	0.000152	0.0014	CcSEcCtD
Simvastatin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000152	0.0014	CcSEcCtD
Simvastatin—Insomnia—Methotrexate—ankylosing spondylitis	0.000151	0.00139	CcSEcCtD
Simvastatin—Nausea—Triamcinolone—ankylosing spondylitis	0.00015	0.00138	CcSEcCtD
Simvastatin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00015	0.00138	CcSEcCtD
Simvastatin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00015	0.00138	CcSEcCtD
Simvastatin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000149	0.00137	CcSEcCtD
Simvastatin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000147	0.00136	CcSEcCtD
Simvastatin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000147	0.00135	CcSEcCtD
Simvastatin—Vomiting—Betamethasone—ankylosing spondylitis	0.000146	0.00134	CcSEcCtD
Simvastatin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000146	0.00134	CcSEcCtD
Simvastatin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000145	0.00134	CcSEcCtD
Simvastatin—Rash—Dexamethasone—ankylosing spondylitis	0.000145	0.00133	CcSEcCtD
Simvastatin—Rash—Betamethasone—ankylosing spondylitis	0.000145	0.00133	CcSEcCtD
Simvastatin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000144	0.00133	CcSEcCtD
Simvastatin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000144	0.00133	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000144	0.00133	CcSEcCtD
Simvastatin—Fatigue—Methotrexate—ankylosing spondylitis	0.000144	0.00133	CcSEcCtD
Simvastatin—Headache—Betamethasone—ankylosing spondylitis	0.000144	0.00132	CcSEcCtD
Simvastatin—Headache—Dexamethasone—ankylosing spondylitis	0.000144	0.00132	CcSEcCtD
Simvastatin—Asthenia—Prednisone—ankylosing spondylitis	0.000143	0.00132	CcSEcCtD
Simvastatin—Pain—Methotrexate—ankylosing spondylitis	0.000143	0.00132	CcSEcCtD
Simvastatin—Pruritus—Prednisone—ankylosing spondylitis	0.000141	0.0013	CcSEcCtD
Simvastatin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000137	0.00127	CcSEcCtD
Simvastatin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000137	0.00126	CcSEcCtD
Simvastatin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000136	0.00126	CcSEcCtD
Simvastatin—Nausea—Dexamethasone—ankylosing spondylitis	0.000136	0.00126	CcSEcCtD
Simvastatin—Nausea—Betamethasone—ankylosing spondylitis	0.000136	0.00126	CcSEcCtD
Simvastatin—Urticaria—Methotrexate—ankylosing spondylitis	0.000133	0.00122	CcSEcCtD
Simvastatin—Dizziness—Prednisone—ankylosing spondylitis	0.000132	0.00122	CcSEcCtD
Simvastatin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000132	0.00122	CcSEcCtD
Simvastatin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000132	0.00122	CcSEcCtD
Simvastatin—Vomiting—Prednisone—ankylosing spondylitis	0.000127	0.00117	CcSEcCtD
Simvastatin—Rash—Prednisone—ankylosing spondylitis	0.000126	0.00116	CcSEcCtD
Simvastatin—Dermatitis—Prednisone—ankylosing spondylitis	0.000126	0.00116	CcSEcCtD
Simvastatin—Headache—Prednisone—ankylosing spondylitis	0.000125	0.00115	CcSEcCtD
Simvastatin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000123	0.00113	CcSEcCtD
Simvastatin—ITGB2—Immune System—KIR3DL1—ankylosing spondylitis	0.000121	0.021	CbGpPWpGaD
Simvastatin—Asthenia—Methotrexate—ankylosing spondylitis	0.00012	0.0011	CcSEcCtD
Simvastatin—ITGB2—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000119	0.0207	CbGpPWpGaD
Simvastatin—Nausea—Prednisone—ankylosing spondylitis	0.000119	0.00109	CcSEcCtD
Simvastatin—Pruritus—Methotrexate—ankylosing spondylitis	0.000118	0.00109	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000114	0.0199	CbGpPWpGaD
Simvastatin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000114	0.00105	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000113	0.0197	CbGpPWpGaD
Simvastatin—Dizziness—Methotrexate—ankylosing spondylitis	0.00011	0.00102	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—CARD9—ankylosing spondylitis	0.000109	0.0189	CbGpPWpGaD
Simvastatin—Vomiting—Methotrexate—ankylosing spondylitis	0.000106	0.000978	CcSEcCtD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000106	0.0184	CbGpPWpGaD
Simvastatin—Rash—Methotrexate—ankylosing spondylitis	0.000105	0.00097	CcSEcCtD
Simvastatin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000105	0.000969	CcSEcCtD
Simvastatin—Headache—Methotrexate—ankylosing spondylitis	0.000105	0.000963	CcSEcCtD
Simvastatin—Nausea—Methotrexate—ankylosing spondylitis	9.91e-05	0.000914	CcSEcCtD
Simvastatin—ITGB2—Extracellular matrix organization—MMP3—ankylosing spondylitis	8.45e-05	0.0147	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IL1R2—ankylosing spondylitis	7.32e-05	0.0127	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—ERAP1—ankylosing spondylitis	6.94e-05	0.0121	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—HLA-C—ankylosing spondylitis	6.84e-05	0.0119	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HLA-C—ankylosing spondylitis	6.57e-05	0.0114	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CARD9—ankylosing spondylitis	6.34e-05	0.011	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.51e-05	0.00957	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.01e-05	0.00872	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—CD79A—ankylosing spondylitis	5.01e-05	0.00871	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	4.71e-05	0.00819	CbGpPWpGaD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	4.57e-05	0.00794	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.08e-05	0.0071	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—HLA-B—ankylosing spondylitis	4.04e-05	0.00703	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—HLA-C—ankylosing spondylitis	3.98e-05	0.00693	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	3.97e-05	0.0069	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HLA-B—ankylosing spondylitis	3.88e-05	0.00675	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	3.63e-05	0.00631	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.6e-05	0.00626	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—CRP—ankylosing spondylitis	3.58e-05	0.00622	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IL1RN—ankylosing spondylitis	3.46e-05	0.00602	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—TLR4—ankylosing spondylitis	3.43e-05	0.00596	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	3.37e-05	0.00587	CbGpPWpGaD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	3.16e-05	0.00549	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CD79A—ankylosing spondylitis	3.04e-05	0.00528	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IL1A—ankylosing spondylitis	2.49e-05	0.00433	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	2.48e-05	0.00431	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CD40LG—ankylosing spondylitis	2.48e-05	0.00431	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	2.47e-05	0.00429	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	2.47e-05	0.00429	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	2.36e-05	0.0041	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—HLA-B—ankylosing spondylitis	2.36e-05	0.0041	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	2.35e-05	0.00408	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—HLA-A—ankylosing spondylitis	2.18e-05	0.0038	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	2.17e-05	0.00378	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CRP—ankylosing spondylitis	2.08e-05	0.00362	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—TLR4—ankylosing spondylitis	2e-05	0.00347	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—B3GNT2—ankylosing spondylitis	1.91e-05	0.00332	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—B3GNT2—ankylosing spondylitis	1.56e-05	0.00271	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—B3GNT2—ankylosing spondylitis	1.32e-05	0.0023	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—B3GNT2—ankylosing spondylitis	1.15e-05	0.002	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—B3GNT2—ankylosing spondylitis	1.08e-05	0.00187	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—B3GNT2—ankylosing spondylitis	9.85e-06	0.00171	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	9.39e-06	0.00163	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—B3GNT2—ankylosing spondylitis	9.04e-06	0.00157	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—B3GNT2—ankylosing spondylitis	6.69e-06	0.00116	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	6.54e-06	0.00114	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	5.66e-06	0.000984	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—B3GNT2—ankylosing spondylitis	5.05e-06	0.000878	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	4.93e-06	0.000857	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	4.65e-06	0.000808	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	4.63e-06	0.000806	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	4.61e-06	0.000801	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	3.04e-06	0.000528	CbGpPWpGaD
